Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis

Annals of the Rheumatic Diseases

Volumn 74, Issue 7, 2015, Pages 1387-1393

  Cortes, A ^a   Maksymowych, W P ^b   Wordsworth, B P ^c   Inman, R D ^d   Danoy, P ^a   Rahman, P ^e   Stone, Ma ^f   Corr, M ^g   Gensler, LianneS ^h   Gladman, D ^i,j,k   Morgan, A ^l   Marzo Ortega, H ^l   Ward, M M ^m   Learch, T J ⁿ   Reveille, J D ^o   Brown, Ma ^a   Weisman, M H ⁿ  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF ALBERTA   (Canada)

^c NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^d TORONTO WESTERN HOSPITAL   (Canada)

^e MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF SAN DIEGO   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j UNIVERSITY HEALTH NETWORK   (Canada)

^k UNIVERSITY HEALTH NETWORK   (Canada)

^l UNIVERSITY OF LEEDS   (United Kingdom)

^m NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

ⁿ CEDARS SINAI MEDICAL CENTER   (United States)

^o UNIVERSITY OF TEXAS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; HLA B ANTIGEN; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE 1; PROSTAGLANDIN SYNTHASE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UNCLASSIFIED DRUG; PTGS1 PROTEIN, HUMAN; TNFRSF11A PROTEIN, HUMAN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BIOSYNTHESIS; CATABOLISM; CERVICAL SPINE RADIOGRAPHY; COHORT ANALYSIS; CONTROLLED STUDY; DENDRITIC CELL; DISEASE DURATION; DISEASE SEVERITY; EUROPEAN; EXON; FEMALE; GENDER; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HLA B GENE; HUMAN; INTRON; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PTGS1 GENE; RANK GENE; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SPINE RADIOGRAPHY; STOKE ANKYLOSING SPONDYLITIS SPINAL SCORE; T LYMPHOCYTE; BONE DEVELOPMENT; CERVICAL SPINE; COMPARATIVE STUDY; GENETICS; LUMBAR VERTEBRA; MIDDLE AGED; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX;

ADULT; BONE RESORPTION; CERVICAL VERTEBRAE; CYCLOOXYGENASE 1; EXONS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOGENESIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 84934906038     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204835     Document Type: Article

References (35)

1. Brown MA, Kennedy LG, MacGregor AJ, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823-8.
2. Pedersen OB, Svendsen AJ, Ejstrup L, et al. Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scand J Rheumatol 2008;37:120-6.
3. Hamersma J, Cardon LR, Bradbury L, et al. Is disease severity in ankylosing spondylitis genetically determined? Arthritis Rheum 2001;44:1396-400.
4. Brophy S, Hickey S, Menon A, et al. Concordance of disease severity among family members with ankylosing spondylitis? J Rheumatol 2004;31:1775-8.
5. Reveille JD, Sims A-M, Danoy P, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010;42:123-7.
6. Evans DM, Spencer CC, Pointon JJ, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011;43:761-7.
7. Lin Z, Bei JX, Shen M, et al. A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nature Genet 2011;44:73-7.
8. Cortes A, Hadler J, Pointon JP, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet 2013;45:730-8.
9. Bartolome N, Szczypiorska M, Sanchez A, et al. Genetic polymorphisms inside and outside the MHC improve prediction of AS radiographic severity in addition to clinical variables. Rheumatology 2012;51:1471-8.
10. Haroon N, Maksymowych WP, Rahman P, et al. Radiographic severity of ankylosing spondylitis is associated with polymorphism of the large multifunctional peptidase 2 gene in the Spondyloarthritis Research Consortium of Canada cohort. Arthritis Rheum 2012;64:1119-26.
11. Ward MM, Hendrey MR, Malley JD, et al. Clinical and Immunogenetic Prognostic Factors for Radiographic Severity in Ankylosing Spondylitis. Arthrit Rheum-Arthr 2009;61:859-66.
12. Wang CM, Ho HH, Chang SW, et al. ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis. Arthritis Res Ther 2012;14:R125.
13. Szczypiorska M, Sanchez A, Bartolome N, et al. ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population. Rheumatology 2011;50:1969-75.
14. Creemers MCW, Franssen MJAM, van't Hof MA, et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 2005;64:127-9.
15. Landewe R, Dougados M, Mielants H, et al. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine. Ann Rheum Dis 2009;68:863-7.
16. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
17. Ward MM, Learch TJ, Weisman MH. Cervical vertebral squaring in patients without Spondyloarthritis. J Rheumatol 2012;39:1900.
18. International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;449:851-61.
19. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
20. Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther 2011;13:101.
21. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
22. Dougall WC, Glaccum M, Charrier K, et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999;13:2412-24.
23. Bachmann MF, Wong BR, Josien R, et al. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J Exp Med 1999;189:1025-31.
24. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, et al. Multiple genetic loci for bone mineral density and fractures. N Engl J Med 2008;358:2355-65.
25. Estrada K, Styrkarsdottir U, Evangelou E, et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 2012;44:491-501.
26. Albagha OM, Visconti MR, Alonso N, et al. Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone. Nat Genet 2010;42:520-4.
27. Hughes AE, Ralston SH, Marken J, et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 2000;24:45-8.
28. Im CH, Kang EH, Ki JY, et al. Receptor activator of nuclear factor kappa B ligand-mediated osteoclastogenesis is elevated in ankylosing spondylitis. Clin Exp Rheumatol 2009;27:620-5.
29. Poddubnyy D, Rudwaleit M, Haibel H, et al. Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis 2012;71:1616-22.
30. Kroon F, Landewe R, Dougados M, et al. Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 2012;71:1623-9.
31. Boersma JW. Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone. Scand J Rheumatol 1976;5:60-4.
32. Wanders A, Heijde D, Landewe R, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005;52:1756-65.
33. Kim TJ, Sung IH, Lee S, et al. HLA-B27 homozygosity has no influence on radiographic damage in ankylosing spondylitis: Observation Study of Korean spondyloArthropathy Registry (OSKAR) data. Joint Bone Spine 2013;80:488-91.
34. Jaakkola E, Herzberg I, Laiho K, et al. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis 2006;65:775-80.
35. Ramiro S, Stolwijk C, van Tubergen A, et al. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Ann Rheum Dis 2013. Published Online First: 16 Aug 2013. doi:10.1136/annrheumdis-2013-204055